Surgical Results of Left Ventricular Lead Implantation for Cardiac Resynchronization Therapy

Ozcan Gur, Selami Gurkan, Demet Ozkaramanli Gur, Habib Cakir, Cayan Akkoyun, Turan Ege

Cardiology Department, Tekirdag State Hospital, Yil Tekirdag, Turkey.
Cardiovascular Surgery Department, Adana Numune Hospital, Yil Tekirdag, Turkey.
Cardiovascular Surgery Department, Medical Faculty, Namik Kemal University, Yil Tekirdag, Turkey.

DOI: 10.4236/wjcs.2013.32004                

Abstract

Objectives: Cardiac resynchronisation therapy (CRT) has proven its effectiveness in patients with symptomatic heart failure [1,2]. Although rewarding, the procedure of biventricular pacemaker implantation is challenging and subsequently fails in 8%-11% of patients. In patients whose left ventricular (LV) electrode cannot be placed transvenously, surgical implantation of an epicardial electrode can be achieved. Methods: Seventeen patients (14 male, 3 female), among whom LV electrode was failed to be placed transvenously, were included into our study. The epicardial LV electrodes were implanted through anterior mini thoracotomy. The patients were followed up for approximate six months and complications, ejection fraction (EF), New York Heart Association (NYHA) class, QRS durations as well as pacing parameters were recorded. Results: Mean age of the patients was 64.4 ± 7.01 (54-79) years. Preoperative mean EF of the patients was 26.1% ± 3.7%. The LV electrode was placed at the optimal place on the lateral LV wall through left sided mini thoracotomy. The mean duration of the operation was 26.76 ± 8.12 minutes and the mean hospital stay was 2.05 ± 0.42 days. There were no intraoperative or postoperative complications. Only 1 patient had LV electrode displaced on the 3rd postoperative month and the patient was reoperated successfully. The EF on the 6th postoperative month was 29.4% ± 3.81% and NYHA class was 2.58 ± 0.5. The etiology of heart failure had no influence on outcome. Conclusions: Surgical implantation of LV lead is associated with low complication rates and excellent follow-up results without exposure to radiation. Thus epicardial leads can be proposed as equal alternative to transvenous leads.

Keywords

Cardiac Resynchronization Therapy; Surgical Epicardial Lead Implantation

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	D. Furwell, N. R. Patel, A. Hall, et al., “How Many People with Heart Failure Are Appropriate for Biventricular Resynchronization?” European Heart Journal, Vol. 21, No. 15, 2000, pp. 1246-1250. doi:10.1053/euhj.1999.1985
[2]	W. T. Abraham, W. G. Fisher, A. L. Smith, et al., “Cardiac Resynchronization in Chronic Heart Failure,” The New England Journal of Medicine, Vol. 346, No. 24, 2002, pp. 1845-1853. doi:10.1056/NEJMoa013168
[3]	F. A. McAlister, J. A. Ezekowitz, N. Wiebe, et al., “Systematic Review: Cardiac Resynchronization in Patients with Symptomatic Heart Failure,” Annals of Internal Medicine, Vol. 141, No. 5, 2004, pp. 381-390. doi:10.7326/0003-4819-141-5-200409070-00101
[4]	A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, et al., “ACC/AHA/HRS 2008 Guidelines for Device-based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons,” Journal of the American Col lege of Cardiology, Vol. 51, No. 21, 2008, pp. 1-62. doi:10.1016/j.jacc.2008.02.032
[5]	J. G. Cleland, J. C. Daubert, E. Erdmann, et al., “Cardiac Resynchronization-Heart failure (CARE-HF) Study Investigators: The Effect of Cardiac Resynchronization on Morbidity and Mortality of Heart Failure,” The New England Journal of Medicine, Vol. 352, No. 15, 2005, pp. 1539-1549. doi:10.1056/NEJMoa050496
[6]	C. Alonso, C. Leclercq, F. R. d’Allonnes, et al., “Six Year Experience of Transvenous Left Ventricular Lead Implantation for Permanent Left Biventricular Pacing in Patients with Advanced Heart Failure: Technical Aspects,” Heart, Vol. 86, No. 4, 2001, pp. 405-410. doi:10.1136/heart.86.4.405
[7]	J. L. Jansens, M. Jottrand, N. Preumont, E. Stoupel and D. de Canniere, “Robotic-Enhanced Biventricular Resynchronization: An Alternative to Endovenous Cardiac Resynchronization Therapy in Chronic Heart Failure,” The Annals of Thoracic Surgery, Vol. 76, No. 2, 2003, pp. 413-417. doi:10.1016/S0003-4975(03)00435-1
[8]	S. Phillip, M. D. Cuculich and S. Joseph, “Cardiac Resynchronization Therapy: What? Who? When? How?” The American Journal of Medicine, Vol. 124, No. 11, 2011, pp. 813-815. doi:10.1016/j.amjmed.2010.09.028
[9]	D. J. Bradley, E. A. Bradley, K. L. Baughman, et al., “Cardiac Resynchronization and Death from Progressive Heart Failure: A Meta-Analysis of Randomized Controlled Trials,” Journal of the American Medical Association, Vol. 289, 2003, pp. 730-740. doi:10.1001/jama.289.6.730
[10]	K. Perisinakis, N. Theocharopoulos, J. Damilakis, et al., “Fluoroscopically Guided Implantation of Modern Cardiac Resynchronization Devices Radiation Burden to the Patient and Associated Risks,” Journal of the American College of Cardiology, Vol. 46, No. 12, 2005, pp. 2335-2339. doi:10.1016/j.jacc.2005.01.070
[11]	C. Butter, T. Schau, J. Meyhoefer, et al., “Radiation Exposure of Patient and Physicians during Implantation and Upgrade of Cardiac Resynchronization Devices,” PACE, Vol. 33, 2010, pp. 1003-1012.
[12]	H. Mair, J. Sachweh, B. Meuris, et al., “Surgical Epicardial Left Ventricular Lead Versus Coronary Sinus Lead Placement in Biventricular Pacing,” European Journal of Cardio-Thoracic Surgery, Vol. 27, No. 2, 2005, pp. 235-242. doi:10.1016/j.ejcts.2004.09.029